GoodRx Holdings, Inc. (GDRX) Analyst Forecast

$4.57

north_east
$0.15 (3.28%)
Day's range
$4.38
Day's range
$4.61

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
06/10/2024 Morgan Stanley Craig Hettenbach $9.50 $8.55   11.11%
05/22/2024 RBC Capital Mark Mahaney $10.00 $7.20   38.89%
05/16/2024 Barclays Stephanie Davis $9.00 $8.06   11.66%
05/16/2024 Raymond James Aaron Kessler $10.00 $7.27   37.55%
04/10/2024 BOCOM International Holdings Company Scott Schoenhaus $9.00 $6.92   30.06%
04/09/2024 KeyBanc Scott Schoenhaus $9.00 $6.74   33.53%
03/25/2024 Wells Fargo Stan Berenshteyn $10.00 $7.23   38.39%
11/13/2023 Goldman Sachs Eric Sheridan $3.00 $4.73   -36.58%
02/28/2022 J.P. Morgan Doug Anmuth $20.00 $16.74   19.47%
02/28/2022 Cowen & Co. Charles Rhyee $22.00 $16.74   31.42%
02/28/2022 Goldman Sachs Eric Sheridan $30.00 $16.74   79.21%
02/28/2022 Deutsche Bank George Hill $20.00 $16.74   19.47%
02/28/2022 Bank of America Securities Justin Post $28.00 $16.74   67.26%
12/20/2021 Stephens Scott Schoenhaus $45.00 $35.83   25.59%
05/13/2021 Citigroup Nicholas Jones CFA $53.00 $30.97   71.13%

GoodRx Holdings, Inc. FAQ's

What analysts cover GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. has been rated by research analysts at Morgan Stanley, RBC Capital, Barclays, Raymond James, BOCOM International Holdings Company, KeyBanc in the past 90 days.